InvestorsHub Logo
Followers 33
Posts 2919
Boards Moderated 1
Alias Born 10/24/2015

Re: jondoeuk post# 143

Saturday, 06/24/2023 8:08:01 PM

Saturday, June 24, 2023 8:08:01 PM

Post# of 1738
They combined the CRISPRomics platform with CRISPR2 tech, which employs randomly paired CRISPR guide libraries, to discover KSQ-004, the lead dual-edited program. The therapy offer the possibility of lower dosing and reduced conditioning.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IOVA News